The evolution of protocol management within eQMS represents another significant advance in clinical trials. Version control ...

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Richard Young, CEO, Cluepoints, offers his key ...

Akebia Therapeutics is currently shifting focus from Auryxia to Vafseo due to Auryxia’s declining revenues. See why I ...

APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Estonia, Latvia and Lithuania — all former Soviet republics that are now in the European Union and NATO — want to block ...

CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced the launch of Nibot, a new generation ...

The Forum for Development and Accountable Governance (FDAG) has cautioned against the growing trend of politically motivated accusations against public officials, citing recent claims made by Dr ...

Bringing new products to market in the era of outsourced clinical trials is reliant on the ability ... mentality at both the operational and management levels. This tends to perpetuate a lack ...

Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...

Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...